Bilibili Inc

Bilibili Inc(BILI)資訊與事件

$16.600

-0.163 (-0.98%)收盤時

BILI 資訊

BILI 事件

8/27 06:30

Bilibili Reports Q2 Revenue of RMB 7.9B

Reports Q2 revenue RMB, consensus RMB7.92B. Average daily active users were 116.5 million, up 7% year over year. "We delivered a solid second quarter with continued growth across our ecosystem," said CEO Rui Chen. "Our high-quality content and interest-based community continue to deepen user engagement, driving DAUs to 117 million, monthly active users to 371 million, and total user time spent up by over 14% year over year. In an era where content is abundant yet attention is scarce, quality and emotional connection matter more than ever, and Bilibili represents the best combination of both in today's internet landscape. As AI enables us to fulfill this mission with greater precision and scale, we remain highly confident in our trajectory ahead". CFO Sam Fan said, "We delivered another quarter of solid financial performance, with continued revenue growth and profit expansion. Total net revenues increased 8% year over year to RMB7.9B, while gross profit grew 10% year over year and gross margin expanded to 37.2%, marking our 16th consecutive quarter of margin improvement. Supported by continued topline growth and stronger operating leverage, net profit increased by 55% year over year. Looking ahead, we will remain disciplined in our investments and actively return value through our share repurchase program, delivering sustainable long-term value for our shareholders."

6/25 09:01

Angion Biomedica Borrow Rate Increases to 183.97%

Latest data shows the largest indicative borrow rate increases among liquid option names include: Beyond Meat (BYND) 67.94% +7.02, Lucid Group (LCID) 45.82% +3.70, BioSig Technologies Inc (STEX) 7.52% +2.35, QXO Inc (QXO) 3.73% +1.69, BioCryst (BCRX) 2.20% +1.44, Rezolve AI Ltd (RZLV) 95.02% +1.35, Tidal Trust II (IRE) 23.77% +1.32, Bilibili (BILI) 2.07% +0.67, Canopy Growth (CGC) 19.33% +0.66, and Angion Biomedica Corp (ELTX) 183.97% +0.65.

6/24 05:30

Bilibili Authorizes $300M Share Repurchase Program

Bilibili announced that its board of directors has authorized a new share repurchase program, under which the company may repurchase up to $300M of its shares for the next 24 months, effective as of the date hereof.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始